APP and Cognitive impairment: Finally, to confirm whether the expression of these molecules is indeed affected in AD, we also carried out qPCR and western blot analysis on 7‐8‐month‐old APP/PS1 model mice of AD, which is very popular in AD research and exhibits obvious cognitive impairment at 7–8 months of age.